Stocks / Alpha Vantage News Sentiment

Biogen Inc. stock underperforms Wednesday when compared to competitors

Shares of Biogen Inc. (BIIB) fell 2.60% on Wednesday to $200.36, underperforming the broader market as the S&P 500 and Dow Jones Industrial Average also declined. This marked the third consecutive day of losses for the stock.